Open-label, Four-period, Randomized Crossover Study to Determine the Comparative Pharmacokinetics of Oral and Intravenous Acetaminophen Administration in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2010
At a glance
- Drugs Paracetamol (Primary) ; Paracetamol (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics; Registrational
- Sponsors Cadence Pharmaceuticals
- 02 Nov 2010 According to a Cadence Pharmaceuticals media release, the US FDA has approved OFIRMEV (IV parcetamol) for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.
- 21 Dec 2006 New trial record.